SOCRA - Society of Clinical Research Associates Society of Clinical Research Associates ICH Good Clinical Practice 1 — Questions and Answers
Question 1: According to ICH E6(R2), which of the following best describes the definition of 'Good Clinical Practice' (GCP)?
- A financial standard for the management of clinical trial budgets and sponsor payments
- An international ethical and scientific quality standard for designing, conducting, recording, and reporting trials involving human subjects (Correct answer)
- A regulatory framework governing the manufacturing and labeling of investigational products only
- A set of guidelines exclusively for statistical analysis and data management in clinical trials
Correct answer: An international ethical and scientific quality standard for designing, conducting, recording, and reporting trials involving human subjects
ICH E6(R2) defines GCP as an international ethical and scientific quality standard for designing, conducting, recording, and reporting trials that involve the participation of human subjects, ensuring that the rights, safety, and well-being of subjects are protected and that clinical trial data are credible.
Question 2: Under ICH E6(R2), what is the primary purpose of an Institutional Review Board (IRB) or Independent Ethics Committee (IEC)?
- To approve the statistical analysis plan and validate the biostatistical methods used in the trial
- To safeguard the rights, safety, and well-being of all trial subjects by reviewing and providing ongoing oversight of the trial (Correct answer)
- To verify the financial disclosures of investigators and ensure there are no conflicts of interest
- To audit the sponsor's quality management system and approve the monitoring plan
Correct answer: To safeguard the rights, safety, and well-being of all trial subjects by reviewing and providing ongoing oversight of the trial
Per ICH E6(R2), the IRB/IEC exists to safeguard the rights, safety, and well-being of human subjects involved in a trial. It reviews protocols, informed consent documents, and other relevant information, and provides continuing oversight throughout the trial.
Question 3: Which ICH E6(R2) section specifies that an investigator must be qualified by education, training, and experience to assume responsibility for the proper conduct of the trial?
- Section 4 — Investigator (Correct answer)
- Section 5 — Sponsor
- Section 6 — Clinical Trial Protocol
- Section 8 — Essential Documents
Correct answer: Section 4 — Investigator
ICH E6(R2) Section 4 outlines investigator responsibilities and qualifications, stating that the investigator must be qualified by education, training, and experience to conduct the trial properly, and must be thoroughly familiar with the investigational product and protocol.
Question 4: According to ICH E6(R2), what is the required timeframe for an investigator to report an unexpected serious adverse event (SAE) to the sponsor?
- Within 7 calendar days of becoming aware of the event
- Within 24 hours of becoming aware of the event, followed by a written report within 8 days (Correct answer)
- Within 48 hours, with a follow-up report within 15 days
- Within 5 working days, as defined by local regulations
Correct answer: Within 24 hours of becoming aware of the event, followed by a written report within 8 days
ICH E6(R2) Section 4.11 requires that all serious adverse events be reported immediately to the sponsor, except those identified in the protocol as not requiring immediate reporting. The standard expectation is immediate (within 24 hours) notification with a detailed written follow-up within 8 days.
Question 5: Under ICH E6(R2), which of the following is considered an essential document that should be in the Trial Master File (TMF) before the clinical phase of the trial begins?
- Completed case report forms (CRFs) for all enrolled subjects
- Signed informed consent forms collected from the first three enrolled subjects
- The signed investigator protocol agreement and CV of the principal investigator (Correct answer)
- Final clinical study report submitted to the regulatory authority
Correct answer: The signed investigator protocol agreement and CV of the principal investigator
ICH E6(R2) Section 8.2 lists essential documents that should be available before the clinical phase begins. These include the signed protocol agreement and the investigator's current CV, which demonstrate the investigator's qualifications and their formal commitment to the protocol.
Question 6: According to ICH E6(R2), what does the term 'direct access' mean in the context of clinical trial monitoring and auditing?
- The sponsor's right to unilaterally modify the trial protocol without notifying the investigator
- Permission to examine, analyze, verify, and reproduce any records and reports that are important to the evaluation of the trial (Correct answer)
- The IRB/IEC's authority to access sponsor financial records related to investigator payments
- Regulatory authority approval to publish the trial's results in a peer-reviewed journal
Correct answer: Permission to examine, analyze, verify, and reproduce any records and reports that are important to the evaluation of the trial
ICH E6(R2) defines 'direct access' as permission to examine, analyze, verify, and reproduce any records and reports that are important to the evaluation of a clinical trial. This right is granted to monitors, auditors, IRB/IECs, and regulatory authorities to ensure data integrity and subject protection.
SOCRA - Society of Clinical Research Associates Society of Clinical Research Associates ICH Good Clinical Practice 1
According to ICH E6(R2), which of the following best describes the definition of 'Good Clinical Practice' (GCP)?